Pulmonary sarcoidosis

P Spagnolo, G Rossi, R Trisolini… - The Lancet …, 2018 - thelancet.com
Sarcoidosis is a granulomatous disease of unknown cause, occurs worldwide and has a
highly variable prevalence. The disease is typically dominant in the lungs, although it can …

Neopterin measurement in clinical diagnosis

A Berdowska… - Journal of clinical …, 2001 - Wiley Online Library
Neopterin is a marker associated with cell‐mediated immunity. It is produced in monocytes/
macrophages primarily upon stimulation with interferon‐γ. Due to its chemical structure …

Alternatively activated alveolar macrophages in pulmonary fibrosis—mediator production and intracellular signal transduction

DV Pechkovsky, A Prasse, F Kollert, KMY Engel… - Clinical …, 2010 - Elsevier
Activated macrophages have been characterized as M1 and M2 according to their
inflammatory response pattern. Here we analyzed the M2 marker expression and …

Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis

MA Judson, RP Baughman, U Costabel… - European …, 2014 - Eur Respiratory Soc
Sarcoidosis is characterised by non-caseating granulomas that secrete pro-inflammatory
cytokines, including interleukin (IL)-12, IL-23, and tumour necrosis factor (TNF)-α …

Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis

LEM Eurelings, JR Miedema, VASH Dalm… - PLoS …, 2019 - journals.plos.org
Background The soluble interleukin 2 receptor (sIL-2R) has been proposed as a marker of
disease activity in patients with sarcoidosis. However, no studies have evaluated whether …

Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis

JP Utz, AH Limper, S Kalra, U Specks, JP Scott… - Chest, 2003 - Elsevier
Background Tumor necrosis factor (TNF)-α is produced by macrophages and other cells,
and is believed to participate in granulomatous inflammation. Targeted antagonism of TNF-α …

Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis

M Ramos-Casals, S Retamozo… - Expert Review of …, 2019 - Taylor & Francis
Introduction: Sarcoidosis is a complex systemic disease with a silent, long-term evolution,
and a heterogeneous clinical presentation. The diagnostic approach is complex with no …

Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen

J Muller-Quernheim, K Kienast, M Held… - European …, 1999 - Eur Respiratory Soc
In a few patients with chronic sarcoidosis, prolonged, unacceptably high doses of
corticosteroids are required to achieve symptomatic relief. In these cases, a corticosteroid …

Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis

MW Ziegenhagen, ME Rothe, M Schlaak… - European …, 2003 - Eur Respiratory Soc
The aim of the present study was to determine which bronchoalveolar lavage fluid (BALF)
and serological parameters reflect the severity of newly diagnosed pulmonary sarcoidosis …

slan-defined subsets of CD16-positive monocytes: impact of granulomatous inflammation and M-CSF receptor mutation

TP Hofer, AM Zawada, M Frankenberger… - Blood, The Journal …, 2015 - ashpublications.org
Human monocytes are subdivided into classical, intermediate, and nonclassical subsets, but
there is no unequivocal strategy to dissect the latter 2 cell types. We show herein that the cell …